Salix Pharmaceuticals, Progenics Pharmaceuticals Announce the Acceptance of Submission to Expand Use of RELISTORby the European Medicines Agency

By: via Benzinga
Salix Pharmaceuticals, Ltd. (Nasdaq: SLXP) and Progenics Pharmaceuticals, Inc. (Nasdaq: PGNX) announced today that the submission to the ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.